|
Research & Development (Quarter)
|
| | 0.23M | | 0.14M | |
|
Selling, General & Administrative (Quarter)
|
| | 0.42M | | 0.37M | |
|
Other Operating Expenses (Quarter)
|
| | 0.16M | | 0.11M | |
|
Operating Expenses (Quarter)
|
| | 0.81M | | 0.62M | |
|
EBIT (Quarter)
|
| | -0.81M | | -0.62M | |
|
Other Non Operating Income (Quarter)
|
| | | | -0.20M | |
|
EBT (Quarter)
|
| | -0.81M | | -0.62M | |
|
Profit After Tax (Quarter)
|
| | -1.46M | | -9.58M | |
|
Income from Continuing Operations (Quarter)
|
| | -0.81M | | -0.62M | |
|
Consolidated Net Income (Quarter)
|
| | -0.81M | | -0.62M | |
|
Income towards Parent Company (Quarter)
|
| | -0.81M | | -0.62M | |
|
Net Income towards Common Stockholders (Quarter)
|
| | -0.81M | | -0.62M | |
|
EPS (Basic) (Quarter)
|
| | -0.08M | | -0.03M | |
|
Shares Outstanding (Weighted Average) (Quarter)
|
542.72M | 581.02M | 10.00 | 31.29M | 20.00 | 645.47M |
|
Shares Outstanding (Diluted Average) (Quarter)
|
| 581.02M | | | | 606.99M |
|
EBITDA (Quarter)
|
| | 1.46M | | 9.58M | |